These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32476471)

  • 1. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies.
    Freckmann G; Buck S; Waldenmaier D; Kulzer B; Schnell O; Gelchsheimer U; Ziegler R; Heinemann L
    J Diabetes Sci Technol; 2021 Jul; 15(4):901-915. PubMed ID: 32476471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin pump use in type 2 diabetes.
    Bode BW
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1(Suppl 1):S17-21. PubMed ID: 20515301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EFFECTIVENESS OF PUMP INSULIN THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (REVIEW)].
    Seidinova A; Ishigov I; Peyami C; Seidinov S
    Georgian Med News; 2018 Nov; (284):51-55. PubMed ID: 30618389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
    Kesavadev J; Jain SM; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anesthesiological perspectives on perioperative management in continuous subcutaneous insulin infusion (CSII): stop or continue?].
    Kietaibl AT; Kietaibl S
    Wien Med Wochenschr; 2020 May; 170(7-8):155-167. PubMed ID: 31654155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
    Raskin P; Bode BW; Marks JB; Hirsch IB; Weinstein RL; McGill JB; Peterson GE; Mudaliar SR; Reinhardt RR
    Diabetes Care; 2003 Sep; 26(9):2598-603. PubMed ID: 12941725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective.
    Kesavadev J; Shankar A; Sadasrian Pillai PB; Saboo B; Joshi S; Krishnan G; Jothydev S
    Curr Diabetes Rev; 2016; 12(4):312-314. PubMed ID: 26643928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump therapy: guidelines for successful outcomes.
    Scheiner G; Sobel RJ; Smith DE; Pick AJ; Kruger D; King J; Green K
    Diabetes Educ; 2009; 35 Suppl 2():29S-41S; quiz 28S, 42S-43S. PubMed ID: 19318690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch Pumps: Are They All the Same?
    Heinemann L; Waldenmaier D; Kulzer B; Ziegler R; Ginsberg B; Freckmann G
    J Diabetes Sci Technol; 2019 Jan; 13(1):34-40. PubMed ID: 30132698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
    Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.